Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296952 · ClinicalTrials.gov registry record · NA
Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
A NA study of Diabetic Retinopathy (DR), sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07296952 is a NA study of Diabetic Retinopathy (DR) that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 60 participants, below the 498-participant average among 5 other Diabetic Retinopathy (DR) trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07296952, a NA study of Diabetic Retinopathy (DR), is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
Conditions Studied
Interventions
- BEHAVIORAL PRONTO-EYE
Study Locations (1)
Illinois
- UI Health - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07296952
The ClinicalTrials.gov registry entry for NCT07296952 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 5 other Diabetic Retinopathy (DR) trials with a reported enrollment target (88% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Retinopathy (DR) appearing as the primary indexed condition, and to 1 intervention - of which PRONTO-EYE is the first listed.
NCT07296952 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07296952 about?
NCT07296952 is a clinical study titled "Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)". This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
What is the current status of trial NCT07296952?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-03. Estimated completion is 2027-06-01.
What conditions does trial NCT07296952 study?
This clinical trial studies the following conditions: Diabetic Retinopathy (DR).
What interventions are being tested in trial NCT07296952?
The interventions under investigation include: PRONTO-EYE (BEHAVIORAL).
Who is sponsoring clinical trial NCT07296952?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07296952 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy (DR)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images
COMPLETED · NA
-
Assessment of AI Program 'DRISTi' as a Screening Tool
RECRUITING
-
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
ACTIVE NOT RECRUITING · Phase 2
-
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.